Principal Investigator
Sangeetha Venugopal
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20250299
Clinical Trial Summary
A Multi-phase, Pharmacokinetics, Safety, and Efficacy Study
of ASTX030 (Azacitidine and Cedazuridine) as Monotherapy
in Subjects with Myeloid Neoplasm or in Combination with
Venetoclax in Subjects with AML (AZTOUND Study)
Phase
Phase III
Funding Agency/Sponsor
Industrial
Disease
Leukemia
Contact Information
Phone Number
305-243-2647